Literature DB >> 14529896

Function, structure, and volume of thyroid gland following allogenic kidney transplantation.

R Junik1, Z Wlodarczyk, M Masztalerz, G Odrowaz-Sypniewska, E Jendryczka, J Manitius.   

Abstract

The aim of the study was to assess the structure, volume, and function of the thyroid gland following kidney transplantation compared with those features of long-term transplant recipients as well as patients with normal native kidney function. Study group A consisted of 30 patients undergoing allogenic kidney transplantation, study group B included 30 long-term kidney transplant recipients who displayed stable renal function at 4 to 11 years following transplantation; control group C comprised 38 patients who were diagnosed or treated for reasons other than thyroid or renal insufficiency. Mean FT-3 concentrations in group A decreased from 2.19 pg/mL preoperatively to 1.52 pg/mL on the first posttransplantation day, returning to the preoperative values (2.06 pg/mL) at 30 days postoperatively. After 6 months the concentrations of thyroid hormones were similar to those among the long-term posttransplantation group (group B), although still lower than those in the control group. Mean thyroid volume in dialyzed patients was 17.10 mL; in the long-term group, 17.60 mL; and in the control group, 15.82 mL between groups that were not statistically significant. Abnormal structure of the thyroid gland was observed in 63% of group A (n = 19), 70% of group B (n = 21), and 29% of the control group. Significantly more abnormal thyroid gland structures were observed among dialyzed or transplanted patients. The thyroid volume was similar in all groups. Significant transient decrease in thyroid stimulating hormone (TSH) and free triidothyronine (FT-3) was not free thyroxine (FT-4) concentrations following kidney transplantation. Occasionally, increase accompanied by a change in FT-4 and TSH concentrations were observed, and antithyroid antibodies were detected only sporadically.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14529896     DOI: 10.1016/j.transproceed.2003.08.003

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  Thyroid function and morphology after a successful kidney transplantation.

Authors:  L Tauchmanovà; R Carrano; T Musella; F Orio; M Sabbatini; G Lombardi; G Fenzi; S Federico; A Colao
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

Review 3.  Thyroid dysfunction and kidney disease: An update.

Authors:  Pedro Iglesias; María Auxiliadora Bajo; Rafael Selgas; Juan José Díez
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

4.  [Thyroid dysfunction in chronic hemodialysis patients].

Authors:  Zbiti Najoua; Hakima Rhouzbiti; Fatima Ezaitouni; Naima Ouzeddoune; Rabia Bayahia; Loubna Benamar
Journal:  Pan Afr Med J       Date:  2010-10-07

5.  Interactions between thyroid disorders and kidney disease.

Authors:  Gopal Basu; Anjali Mohapatra
Journal:  Indian J Endocrinol Metab       Date:  2012-03

6.  Thyroid disease and cancer in kidney transplantation: a single-center analysis.

Authors:  Massimiliano Veroux; Giuseppe Giuffrida; Salvatore Lo Bianco; Matteo Angelo Cannizzaro; Daniela Corona; Alessia Giaquinta; Chiara Palermo; Fausto Carbone; Anna Carbonaro; Maria Teresa Cannizzaro; Rossella Gioco; Pierfrancesco Veroux
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.